A randomized study of adjuvant chemotherapy for malignant phyllodes tumours of the breast

Morales-Vásquez, Flavia; González-Angulo, Ana M.; López-Basave, Horacio Noé; Cortés, Daniel; Broglio, Kristine; Alvarado, Alberto; Gallardo, Dolores; Mohar, A.; Delagarza, J.; Hortobagyi, G. N.; Lara, Fernando

doi:10.1200/jco.2005.23.16_suppl.574

Cited by 5 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Surgical management has been the mainstay of treatment for phyllodes tumors, but the optimal surgery and margin size to prevent recurrence and metastasis remain a debated topic. Jang et al 23 sought to define clinicopathologic risk factors for local recurrence of phyllodes tumors. They conducted a retrospective review of 164 patients who underwent surgical management for phyllodes and found positive resection margin and tumor size were predictive of local recurrence.…”

Section: Treatmentmentioning

confidence: 99%

A Single-center Experience and Review of the Literature: 64 Cases of Phyllodes Tumors to Better Understand Risk Factors and Disease Management

Lightner

Shurell

Dawson

et al. 2015

The American Surgeon

View full text Add to dashboard Cite

Phyllodes tumors of the breast are rare fibroepithelial tumors that are characterized as benign, borderline, or malignant based on cellular characteristics such as stromal overgrowth and number of mitoses. Currently, there is a lack of consensus on risk factors and management of patients with phyllodes tumors, which has led to variation in treatment patterns as well as patient outcomes across many institutions. This study seeks to understand the clinicopathologic features, risk factors for local and metastatic recurrence, and clinical outcomes of patients with phyllodes tumors to better define optimal treatment patterns.

show abstract

Section: Treatmentmentioning

confidence: 99%

A Single-center Experience and Review of the Literature: 64 Cases of Phyllodes Tumors to Better Understand Risk Factors and Disease Management

Lightner

Shurell

Dawson

et al. 2015

The American Surgeon

View full text Add to dashboard Cite

show abstract

Cystosarcoma phyllodes of the breast: a rare diagnosis: case studies and review of literature

Kraemer

Hoffmann

Roehm

et al. 2007

Arch Gynecol Obstet

View full text Add to dashboard Cite

Cystosarcoma phyllodes (CP), otherwise known as phyllodes tumour (PT) of the breast, is a very rare but locally aggressive fibroepithelial tumour in its malignant form, and accounts for 0.3-1% of all breast neoplasias. Using 4 cases reports with different histological classifications as examples (benign-borderline-malignant), we describe the (differential) diagnosis and treatment options of this tumour entity and give an additional review of the available literature.

show abstract

Recent clinical studies of the immunomodulatory drug (IMiD®) lenalidomide

Bartlett¹,

Tozer²,

Stirling³

et al. 2005

Br J Cancer

View full text Add to dashboard Cite

show abstract

A randomized study of adjuvant chemotherapy for malignant phyllodes tumours of the breast

Cited by 5 publications

References 0 publications

A Single-center Experience and Review of the Literature: 64 Cases of Phyllodes Tumors to Better Understand Risk Factors and Disease Management

A Single-center Experience and Review of the Literature: 64 Cases of Phyllodes Tumors to Better Understand Risk Factors and Disease Management

Cystosarcoma phyllodes of the breast: a rare diagnosis: case studies and review of literature

Recent clinical studies of the immunomodulatory drug (IMiD®) lenalidomide

Contact Info

Product

Resources

About